Trials / Completed
CompletedNCT02661438
Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
Multicenter Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation in Subjects With Non-Cystic Fibrosis Bronchiectasis (NCFB) or Chronic Obstructive Pulmonary Disease (COPD) Using Matching Placebo
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo to Ciprofloxacin DPI (BAYQ3939) | Placebo to Ciprofloxacin DPI, 3 doses during test session, 1 additional dose for patients during device training |
Timeline
- Start date
- 2016-01-12
- Primary completion
- 2016-03-17
- Completion
- 2016-03-17
- First posted
- 2016-01-22
- Last updated
- 2018-12-19
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02661438. Inclusion in this directory is not an endorsement.